CLU
0.015
150%
HYT
0.006
-57.1%
WNX
0.115
105.4%
TKM
0.058
-47.3%
ITM
0.053
71%
LML
0.007
-46.2%
AU1
0.034
54.5%
LKO
0.265
-37.6%
MRQ
0.003
50%
ATC
0.002
-33.3%
QEM
0.022
46.7%
OVT
0.002
-33.3%
AQZ
0.83
41.9%
TMX
0.002
-33.3%
ALB
0.056
40%
ARO
0.003
-25%
NFM
0.007
40%
NES
0.003
-25%
SLD
0.6
39.5%
ALU
0.67
-23.9%
SNT
0.035
34.6%
BTN
0.012
-20%
ABE
0.02
33.3%
ENL
0.004
-20%
HIQ
0.008
33.3%
FIN
0.004
-20%
MHM
0.16
33.3%
MAY
0.004
-20%
SMM
0.012
33.3%
PCL
0.008
-20%
WC1
0.016
33.3%
IBR
0.056
-18.8%
FAL
0.55
32.5%
BPG
0.295
-18.1%
MYE
0.53
32.5%
AGE
0.044
-17%
PPK
0.45
32.4%
CD2
0.3
-16.7%
AHK
0.315
31.3%
ZEU
0.005
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf